Company / AR per Share
Myriad Genetics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.42
FY2025
5-year range
$1.29 / $1.52
FY2021-FY2025
Trend
-6.3%
vs FY2024
Sector context
#48 of 115
Health Care
What the data says
At $1.42, Myriad Genetics, Inc.'s ar per share ranks #48 of 115 in the Health Care sector. AR per Share has fluctuated over the past 10 years, ranging from $1.14 in FY2016 to $1.94 in FY2019.
Based on SEC 10-K filings.
1.42 in FY2025 with a 5-year CAGR of +1.6%.
Declined from $1.52 to $1.42 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +0.9%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
#48 of 115 in Health CareTop 42% of 115This company $1.42 Sector average $27.05
▼
-94.8% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 6.3% year-over-year.
- Ranks #48 out of 115 companies in the Health Care sector.
- Peak ar per share was recorded in FY2019.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | -6.3% |
| FY2024 | $1.51 | -0.1% |
| FY2023 | $1.52 | +9.7% |
| FY2022 | $1.38 | +6.9% |
| FY2021 | $1.29 | -1.2% |
| FY2020 | $1.31 | -32.5% |
| FY2019 | $1.94 | +34.2% |
| FY2018 | $1.44 | +19.0% |
| FY2017 | $1.21 | +6.7% |
| FY2016 | $1.14 | +9.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026